Katherine Haan, MBA, is a Senior Staff Writer for Forbes Advisor and a former financial advisor turned international bestselling author and business coach. For more than a decade, she’s helped small ...

Tailor your Garmin watch setup to your running needs by focusing on key metrics that support your training without overwhelming you, starting simple and adding features as you go. Customize data ...

How I got my business emails through spam filters with SPF, DKIM, and DMARC ...

The iPhone 15 Pro and iPhone 15 Pro Max both have fantastic battery life. It’s roughly the same as the iPhone 14 Pro and Pro Max from last year (just slightly longer in our testing), but that makes ...

A quick look at the table above will show that these two phones are very similar. This isn’t surprising, as they are only a generation apart so upgrades tend to be incremental rather than ...

CVE-2026-8732 in WP Maps Pro lets unauthenticated attackers create admin accounts on 15,000+ WordPress sites. Wordfence blocked 2,858 attacks in 24 hours.

iPhone owners could receive up to $95 under a proposed $250 million settlement resolving claims that Apple misled customers about Siri's artificial intelligence features, according to a recent court ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Learn what a crypto wallet is and how to create one Manoj is a writer who ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Elysse Bell is a finance and business writer for Investopedia. She writes about small business, personal finance, technology, and more. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. As Managing Editor, I lead ...

From shrinking drug development timelines to scouting potential acquisitions, the recent run of first-quarter earnings results marked a shift for Big Pharma from AI hype to explaining how the ...